Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Website makes no sense

<< Previous

Bullboard Posts

Next >>

Comment by pp19888on May 05, 2020 11:32am

78 Views

Post# 30987888

RE:RE:RE:RE:RE:Website makes no sense

It's not TSX who gives phase 1 trial approval, looks like you are newbie in this market. Gl. Their very first release was misleading about recruiting patients for trial and give them immunoboost but before all that happens their trial must be approved by US FDA which hasn't imo. Let's forget about all this. Why it take more than a month to recruit 10 patients in states where everyday more than 2000 dying because of covid 19. The problem is they can't give their drug to anybody without getting permission from FDA.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario